• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec11
US Bank Downgrades Alcon's Stock Rating to 'Underperform'
16:03
Dec9
Alcon Revises Acquisition Agreement for Dexcel with 1.6 Billion USD
13:30
Dec1
BIOOPTIX and ALCON Reach Milestone-Based Preclinical Research Agreement
01:41
Nov18
KeyBanc Analyst Reiterates Buy Rating on Alcon
09:17
Nov14
Wells Fargo analyst maintains Alcon's hold rating and provides target price
05:06
Nov13
RBC Downgrades Alcon's 2025 Fiscal Year Forecast
11:52

Schedules & Filings

Schedules
Filings
Nov11
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.614 B, Net Income 237 M, EPS 0.48

Aug19
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.596 B, Net Income 176 M, EPS 0.35

May15
Distribution Plan(EST)

Cash dividend 0.182 CHF

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More